ABO incompatible living donor kidney transplantation: A dream come true. Experience of Hospital Clínic of Barcelona;Trasplante renal ABO incompatible: De un sueño a una realidad. Experiencia del Hospital Clínic de Barcelona

Nefrologia

Volumn 30, Issue 1, 2010, Pages 54-63

  Salinas, Federico Oppenheimer ^a   Revuelta, I ^a   Serra, N ^a   Lozano, M ^a   Gutierrez Dalmau A ^b   Esforzado, N ^a   Cofan F ^a   Ricart, M J ^a   Torregrosa, J V ^a   Crespo, M ^a   Paredes, D ^a   Martorell, J ^a   Alcaraz, A ^a   Campistol, J M ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

ABO incompatibility; Immunoadsorption; Living donor kidney transplantation; Rituximab

Indexed keywords

EID: 77953147779     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2009.Dic.5695     Document Type: Article

References (41)

1. The Organ Procurement and Transplantation Network. United Network for Organ Sharing (UNOS). (Accessed March 31, 2009, at http://www.optn.org).
2. Wolfe RA, Merion RM, Roys EC, Port FK. Trends in Organ Donation and Transplantation in the United States, 1998-2007. Am J Transplant 2009;9(Part 2):869-78.
3. McCullough KP, Keith DS, Meyer KH, Stock PG, Brayman KL, Leichtman AB. Kidney and Pancreas Transplantation in the United States, 1998-2007. Access for Patients with Diabetes and End-Stage Renal Disease. Am J Transplant 2009;9 (Part 2):894-906.
4. Ellison MD, McBride MA, Taranto SE, Delmonico FL, Kauffman HM. Living kidney donors in need of kidney transplants: a report from the Organ Procurement and Transplantation Network. Transplantation 2002;74:1349-51.
5. Montgomery RA, Simpkins CE, Segev DL. New Options for Patients with Donor Incompatibilities. Transplantation 2006;82:164-5.
6. Davis CL, Delmonico FL. Living-donor kidney transplantation: A review of the current practices for the live donor. J Am Soc Nephrol 2005;16:2098-110.
7. Brynger H, Blohmé I, Lindholm A, Rydberg L, Samuelsson B, Sandberg L. Transplantation of cadaveric kidneys from blood group A2 donors. Transplant Proc 1982;14:195-8.
8. Rydberg L, Breimer ME, Sanuelsson BE, Brynger H. Blood group ABO incompatible (A2 to O) kidney transplantation in human subjects: A clinical, serologic, and biochemical approach. Transplant Proc 1987;19:4528-37.
9. Rydberg L. ABO incompatibility in solid organ transplantation. Transfus Med 2001;11:325-42.
10. Slapak M, Digard N, Ahmed M, et al. Renal transplantation across the ABO barrier-A 9-year experience. Transplant Proc 1990;22:1425-8.
11. Alexandre GPJ, Squifflet JP, De Bruyere M, Latinne D, Reding R, Gianello P, et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987;19:4538-42.
12. Gloor JM, Lager DJ, Moore SB, Pineda AA, Fidler ME, Larson TS, et al. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation 2003;75:971-7.
13. Nelson PW, Landreneau MD, Luger AM, Pierce GE, Ross G, Shield CF 3rd, et al. Ten years experience in transplantation of A2 kidneys into B and O recipients. Transplantation 1998;65:256-60.
14. Rydberg L, Bengtsson A, Samuelsson O, Nilsson K, Breimer ME. In vitro assessment of a new immunosorbent with synthetic carbohydrates attached to Sepharose. Transplant Int 2005;17:666-72.
15. Tydén G, Kumlien G, Genberg H, Sandberg J, Lundgren T, Fehrman I. ABO incompatible kidney transplantations without splenectomy, using antigenspecific immunoadsorption and Rituximab. Am J Transplant 2005;5:145-8.
16. Genberg H; Kumlien G, Wennberg L, Tydén G. Long-Term Results of ABO-Incompatible Kidney Transplantation With Antigen-Specific Immunoadsorption and Rituximab. Transplantation 2007;84:S44-S47.
17. Nordén G, Briggs D, Cockwell P, Lipkin G, Mjömstedt L, Mölne J, et al. Blood group ABO incompatible live donor renal transplantation using carbohydrate based immunoadsorbtion and anti-CD20 antibody treatment. Xenotransplantation 2006;13(6):148-53.
18. Donauer J, Wilpert J, Geyer M, Schwertfeger E, Kirste G, Drognitz O, et al. ABO incompatible kidney transplantation using antigenspecific immunoadsoption and rituximab: a single center experience. Xenotransplantation 2006;13:108-10.
19. Ichimaru N, Takahara S. Japan's experience with living-donor kidney transplantation across ABO barriers. Nat Clin Pract Nephr 2008;4(12):682-92.
20. Tanabe K. Japanese Experience of ABO-Incompatible Living Kidney Transplantation. Transplantation 2007;84:S4-S7.
21. Kumlien G, Ullstrom L, Losvall A, Persson LG, Tyden G. Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies. Transfusion 2006;46:1568-75.
22. Crespo M, Esforzado N, Ricart MJ, Oppenheimer F. Resultados a largo plazo del trasplante renal de donante vivo: Supervivencia de injerto y receptor. Arch Esp Urol 2005;58(6):537-42.
23. Gebel HM, Bray RA. Approaches for transplanting the sensitized patient: biology versus pharmacology. Nephrol Dial Transplant 2008;23:2454-7.
24. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, et al. Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions. Am J Transplant 2008;8:1-8.
25. Higgins R, Lowe D, Zehnder D, Krishnan N, Hamer R, Briggs D. New choices for patients needing kidney transplantation across antibody barriers. J Renal Care 2008; 43(2):85-93.
26. Genberg H, Kumlien G, Wennberg L, Berg U, Tydén G. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up. Transplantation 2008; 85(12):1745-54.
27. Sonnenday CJ, Warren DS, Cooper M, Samaniego M, Haas M, King KE, et al. Plasmapheresis, CMV Hyperimmune Globulin, and Anti-CD20 Allow ABO-Incompatible Renal Transplantation Without Splenectomy. Am J Transplant 2004;4:1315-22.
28. Séller M, Donauer J, Pisarski P, Drognitz O, Huotari CS, Wisniewski U, et al. Preemptive Postoperative Antigen-Specific Immunoadsorption in ABO-Incompatible Kidney Transplantation: Necessary or Not? Transplantation 2007;84:S40-S43.
29. Galliford J, Charif R, Chan KK, Loucaidou M, Cairns T, Cook HT, et al. ABO Incompatible Living Renal Transplantation With a Steroid Sparing Protocol. Transplantation 2008;86:901-6.
30. Oettl T, Halter J, Bachmann A, Guerke L, Infanti L, Oertli D, et al. ABO blood group-incompatible living donor kidney transplantation: a prospective, single-centre analysis including serial protocol biopsias. Nephrol Dial Transplant 2009;24:298-303.
31. Norden G, Breimer ME. ABO-incompatible kidney transplantation: overview and new strategies. Trends in Transplantation 2007;1:61-8.
32. Kaplan B, Gangemi A, Thielke J, Oberholzer J, Sankary H, Benedetti E. Successful rescue of refractory severe antibody mediated rejection with splenectomy. Transplantation 2007;83:99-100.
33. Aranda JM, Scornik JC, Normann SJ, Lottenberg, R, Schofield R, Pauly DF, et al. Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report. Transplantation 2002;73:907-10.
34. Becker YT, Becker BN, Pirsch JD, Sollinger HW. Rituximab as treatment for refractory kidney transplant rejection. Am J Transplant 2004;4:996-1001.
35. Tydén G, Kumlien G, Genberg H, Sandberg J, Sedigh A, Lundgren T, et al. The Stockholm experience with ABO-incompatible kidney transplantations without splenectomy. Xenotransplantation 2006;13:105-7.
36. Matas AJ, Gillingham KJ, Humar A, Kandaswamy R, Sutherland DER, Payne WD, et al. 2202 Kidney Transplant Recipients with 10 Years of Graft Function: What Happens Next? Am J Transplant 2008;8:2410-9.
37. Oppenheimer F, Aljama P, Asensio C, Bustamante J, Crespo JC, Guirado LL. The impact of donor age on the results of renal transplantation. Nephrol Dial Transplant 2004;19(Suppl 3):S11-S15.
38. Troisi R, Noensl L, Montalti R, Ricciardi S, Philippe J, Praet M, et al. ABO-mismatch adult living donor liver transplantation using antigen-specific immunoadsorption and quadruple immunosuppression without splenectomy. Liver Transpl 2006;12(9):1412-7.
39. Cole EH, Johnston O, Rose KL, Gill JS. Impact of Acute Rejection and New-Onset Diabetes on Long-Term Transplant Graft and Patient Survival. Clin J Am Soc Nephrol 2008;3:814-21.
40. Morales JM, Marcén R, Andrés A, González Molina M, Del Castillo D, Cabello M, et al. Renal transplantation in the modern immunosuppressive era in Spain: four-year results from a multicenter database focus on post-transplant cardiovascular disease. Kidney Int 2008;74(Suppl 111):S94-S99.
41. Montgomery RA, Locke JE, King KE, Segev DL, Warren DS, Kraus ES, et al. ABO Incompatible Renal Transplantation: A Paradigm Ready for Broad Implememtation. Transplantation 2009;87:1246-55.